Patents by Inventor Corinna Mauth
Corinna Mauth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10238775Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 60 to 80%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.Type: GrantFiled: March 31, 2017Date of Patent: March 26, 2019Assignee: STRAUMANN HOLDING AGInventors: Corinna Mauth, Aaldert-Rens Molenberg
-
Patent number: 10098983Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 80 to 95%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.Type: GrantFiled: March 31, 2017Date of Patent: October 16, 2018Assignees: STRAUMANN HOLDING AG, CAM BIOCERAMICS B.V.Inventors: Corinna Mauth, Aaldert-Rens Molenberg
-
Publication number: 20170203000Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 80 to 95%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.Type: ApplicationFiled: March 31, 2017Publication date: July 20, 2017Applicants: STRAUMANN HOLDING AG, CAM BIOCERAMICS B.V.Inventors: Corinna MAUTH, Aaldert-Rens MOLENBERG
-
Publication number: 20170203008Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 60 to 80%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.Type: ApplicationFiled: March 31, 2017Publication date: July 20, 2017Applicant: STRAUMANN HOLDING AGInventors: Corinna MAUTH, Aaldert-Rens MOLENBERG
-
Publication number: 20150032221Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 80 to 95%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.Type: ApplicationFiled: February 12, 2013Publication date: January 29, 2015Inventors: Corinna Mauth, Aaldert-Rens Molenberg
-
Publication number: 20150025651Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 60 to 80%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.Type: ApplicationFiled: February 12, 2013Publication date: January 22, 2015Inventors: Corinna Mauth, Aaldert-Rens Molenberg
-
Patent number: 8466101Abstract: Pharmaceutical, dental and/or cosmetic composition consisting of purified Enamel Matrix Derivative (EMD) proteins which have a molecular weight between 1 and 55 kDa, formulated in a suitable pharmaceutical carrier. The composition is depleted of proteins which have a molecular weight between 56 and 160 kDa and an iso-electric point between 3-10. The purified Enamel Matrix Derivative (EMD) proteins are depleted of proteinase inhibitors, such as ?1-antichymotrypsin and/or Fetuin A. The composition is preferably used for promoting and/or inducing regeneration of hard tissue, tissue mineralization, bone growth and/or bone regrowth, regeneration of dentin, cementogenesis, and/or binding between parts of living mineralized tissue, for bonding of a piece of living mineralized tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.Type: GrantFiled: October 29, 2010Date of Patent: June 18, 2013Assignee: Straumann Holding AGInventors: P. Mark Bartold, Peter S. Zilm, Corinna Mauth, Ruzica Ranevski
-
Publication number: 20120309685Abstract: Pharmaceutical, dental and/or cosmetic composition consisting of purified Enamel Matrix Derivative (EMD) proteins which have a molecular weight between 1 and 55 kDa, formulated in a suitable pharmaceutical carrier. The composition is depleted of proteins which have a molecular weight between 56 and 160 kDa and an iso-electric point between 3-10. The purified Enamel Matrix Derivative (EMD) proteins are depleted of proteinase inhibitors, such as ?1-antichymotrypsin and/or Fetuin A. The composition is preferably used for promoting and/or inducing regeneration of hard tissue, tissue mineralization, bone growth and/or bone regrowth, regeneration of dentin, cementogenesis, and/or binding between parts of living mineralized tissue, for bonding of a piece of living mineralized tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.Type: ApplicationFiled: October 29, 2010Publication date: December 6, 2012Applicant: Straumann Holding AGInventors: P. Mark Bartold, Peter S. Zilm, Corinna Mauth, Ruzica Ranevski
-
Publication number: 20110312891Abstract: Isolated active compound of a naturally occurring fraction of Enamel Matrix Derivatives (EMD), having at least one of each two N-terminal polypeptide fragments of amelogenin, which are at least 95% identical to an amino acid sequence as shown in SEQ. ID. No:1 and/or 2. The invention relates to the use of said isolated active compound of a fraction and/or of the fraction itself, and/or the at least one of each two polypeptide fragments for use as a medicament and/or for the manufacture of a pharmaceutical composition for a variety of different medical indications such as inducing and/or promoting cementogenesis, bone growth and/or binding between parts of living mineralised tissue, for bonding of a piece of living mineralised tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, for inducing regeneration of dentin, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.Type: ApplicationFiled: June 29, 2009Publication date: December 22, 2011Applicant: Straumann Holding AGInventors: Stina Gestrelius, Michel Dard, Ruzica Ranevski, S. Petter Lyngstadaas, Corinna Mauth